Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Naoki Nishimura (Chuo City, Tokyo, Japan), Naoki Nishimura, Hiroshi Nakaoka, Torahiko Jinta, Yutaka Tomishima, Kohei Okafuji, Noboru Uchiyama, Naohiko Chohnabayashi. Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study. Eur Respir J 2015; 46: Suppl. 59, 2632

Member's Comments

No comment yet.

Related content which might interest you: The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003 Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis Source: Eur Respir J 2012; 40: 1191-1200 Year: 2012 Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Therapeutic outcomes for cavitary Mycobacterium avium complex (MAC) lung disease Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014 Clinical nalysis of glycopeptidolipid core antigen IgA antibodies for cases in which it is difficult to obtain a definite diagnosis of mycobacterium avium complex pulmonary disease Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease; cross-sectional study Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Characteristics of pulmonary MAC disease diagnosed later in follow-up after negative mycobacterial cultures by bronchoscopy Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Analysis of clinical course after pulmonary resection for mycobacterium avium complex lung disease in our hospital Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions Year: 2014 Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016 Year: 2017 Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases Source: Eur Respir J 2001; 18: Suppl. 33, 443s Year: 2001 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011